Position in LLY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$78,436,731
+$41,453,700 QoQ
Shares Held
65,395
+62.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
#432
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $235,547,820 across 12 Drug Manufacturers - General names. LLY ranks #1 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
65,395 | $78,436,731 | |
| 2 | JNJ |
Johnson & Johnson
|
184,287 | $46,803,369 | |
| 3 | AMGN |
Amgen Inc
|
97,295 | $35,232,465 | |
| 4 | ABBV |
AbbVie Inc.
|
91,033 | $22,907,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
144,784 | $18,292,010 | |
| 6 | MRK |
Merck & Co., Inc.
|
130,290 | $16,742,265 | |
| 7 | PFE |
Pfizer Inc
|
272,912 | $6,571,720 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
94,227 | $5,429,359 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,436,731 | 65,395 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $36,983,031 | 40,209 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $44,925,926 | 41,804 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $35,345,975 | 46,325 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $32,558,629 | 41,767 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $29,977,229 | 36,296 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $28,817,988 | 37,329 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $29,261,712 | 33,029 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $28,012,457 | 30,940 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $22,080,060 | 28,382 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $13,942,280 | 23,918 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $12,218,633 | 22,748 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $10,632,714 | 22,672 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $7,923,042 | 23,071 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $9,446,720 | 25,822 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $9,243,283 | 28,586 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $11,521,188 | 35,534 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $8,302,725 | 28,993 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $7,537,491 | 27,288 | Shares | Sole | 2022-01-11 | |
| 2021-09-30 | $6,504,519 | 28,152 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $5,585,139 | 24,334 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $3,025,363 | 16,194 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $2,437,205 | 14,435 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,961,413 | 13,251 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,897,592 | 11,558 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,629,266 | 11,745 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||